| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SIM.3241 |
| P8608 | Fatcat ID | release_st2nhgouurcgrkq62xmyif5wu4 |
| P932 | PMC publication ID | 2423233 |
| P698 | PubMed publication ID | 18404622 |
| P5875 | ResearchGate publication ID | 5447296 |
| P50 | author | Charles Hendricks Brown | Q37367747 |
| Robert D. Gibbons | Q46996511 | ||
| Eisuke Segawa | Q96605314 | ||
| P2093 | author name string | J John Mann | |
| Kush Kapur | |||
| Dulal K Bhaumik | |||
| Kwan Hur | |||
| Sue M Marcus | |||
| Anup K Amatya | |||
| George Karabatsos | |||
| P2860 | cites work | Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials | Q24556639 |
| Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets | Q31117436 | ||
| The relationship between antidepressant prescription rates and rate of early adolescent suicide | Q34577873 | ||
| Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents | Q34582162 | ||
| The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. | Q34998784 | ||
| Youth suicide risk and preventive interventions: a review of the past 10 years | Q35089705 | ||
| ACNP Task Force report on SSRIs and suicidal behavior in youth | Q36327813 | ||
| Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants | Q37246423 | ||
| Anti-depressants, suicide, and drug regulation | Q40437128 | ||
| Measuring errors and adverse events in health care | Q41267670 | ||
| Antidepressants and suicide risk in the United States, 1985-1999. | Q45156796 | ||
| The relationship between antidepressant medication use and rate of suicide | Q45256271 | ||
| Suicidality in pediatric patients treated with antidepressant drugs | Q46977975 | ||
| Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden | Q47290129 | ||
| Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents | Q47444850 | ||
| The sales of antidepressants and suicide rates in Norway and its counties 1980-2004. | Q51715116 | ||
| Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants | Q51920016 | ||
| A semi-parametric Bayesian approach to generalized linear mixed models. | Q52230191 | ||
| Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study | Q53281125 | ||
| Suicide risk during antidepressant treatment. | Q55041518 | ||
| Suicide attempts among patients starting depression treatment with medications or psychotherapy | Q80557476 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicide | Q10737 |
| regression analysis | Q208042 | ||
| P304 | page(s) | 1814-1833 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Statistics in Medicine | Q7604438 |
| P1476 | title | Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide | |
| P478 | volume | 27 |
| Q33535446 | Advances in analysis of longitudinal data |
| Q38893468 | Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model |
| Q29227459 | An Overview of Research and Evaluation Designs for Dissemination and Implementation |
| Q37024628 | Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database. |
| Q30651235 | Data Mining of the Public Version of the FDA Adverse Event Reporting System |
| Q33617259 | Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations |
| Q28476251 | Drugs associated with more suicidal ideations are also associated with more suicide attempts |
| Q37964440 | Methods for observational post-licensure medical product safety surveillance |
| Q33739346 | Post-approval drug safety surveillance |
| Q35069464 | Should We Treat Depression with drugs or psychological interventions? A Reply to Ioannidis |
| Q37868003 | Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned? |
| Q34608587 | Suicidality and montelukast |
Search more.